These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
279 related articles for article (PubMed ID: 17074756)
1. The DNA binding activities of Smad2 and Smad3 are regulated by coactivator-mediated acetylation. Simonsson M; Kanduri M; Grönroos E; Heldin CH; Ericsson J J Biol Chem; 2006 Dec; 281(52):39870-80. PubMed ID: 17074756 [TBL] [Abstract][Full Text] [Related]
2. Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor beta response. Tu AW; Luo K J Biol Chem; 2007 Jul; 282(29):21187-96. PubMed ID: 17478422 [TBL] [Abstract][Full Text] [Related]
3. Smad3 is acetylated by p300/CBP to regulate its transactivation activity. Inoue Y; Itoh Y; Abe K; Okamoto T; Daitoku H; Fukamizu A; Onozaki K; Hayashi H Oncogene; 2007 Jan; 26(4):500-8. PubMed ID: 16862174 [TBL] [Abstract][Full Text] [Related]
4. Acetylation of KLF5 alters the assembly of p15 transcription factors in transforming growth factor-beta-mediated induction in epithelial cells. Guo P; Zhao KW; Dong XY; Sun X; Dong JT J Biol Chem; 2009 Jul; 284(27):18184-93. PubMed ID: 19419955 [TBL] [Abstract][Full Text] [Related]
5. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling. Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129 [TBL] [Abstract][Full Text] [Related]
6. Erbin inhibits transforming growth factor beta signaling through a novel Smad-interacting domain. Dai F; Chang C; Lin X; Dai P; Mei L; Feng XH Mol Cell Biol; 2007 Sep; 27(17):6183-94. PubMed ID: 17591701 [TBL] [Abstract][Full Text] [Related]
7. Requirement of a dynein light chain in TGFbeta/Smad3 signaling. Jin Q; Gao G; Mulder KM J Cell Physiol; 2009 Dec; 221(3):707-15. PubMed ID: 19711352 [TBL] [Abstract][Full Text] [Related]
8. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells. Ko H; So Y; Jeon H; Jeong MH; Choi HK; Ryu SH; Lee SW; Yoon HG; Choi KC Cancer Lett; 2013 Jul; 335(1):205-13. PubMed ID: 23419524 [TBL] [Abstract][Full Text] [Related]
9. The transcription factor GLI1 interacts with SMAD proteins to modulate transforming growth factor β-induced gene expression in a p300/CREB-binding protein-associated factor (PCAF)-dependent manner. Nye MD; Almada LL; Fernandez-Barrena MG; Marks DL; Elsawa SF; Vrabel A; Tolosa EJ; Ellenrieder V; Fernandez-Zapico ME J Biol Chem; 2014 May; 289(22):15495-506. PubMed ID: 24739390 [TBL] [Abstract][Full Text] [Related]
10. Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT. Soond SM; Chantry A Oncogene; 2011 May; 30(21):2451-62. PubMed ID: 21258410 [TBL] [Abstract][Full Text] [Related]
11. Myocardin enhances Smad3-mediated transforming growth factor-beta1 signaling in a CArG box-independent manner: Smad-binding element is an important cis element for SM22alpha transcription in vivo. Qiu P; Ritchie RP; Fu Z; Cao D; Cumming J; Miano JM; Wang DZ; Li HJ; Li L Circ Res; 2005 Nov; 97(10):983-91. PubMed ID: 16224064 [TBL] [Abstract][Full Text] [Related]
12. RAP250 is a coactivator in the transforming growth factor beta signaling pathway that interacts with Smad2 and Smad3. Antonson P; Jakobsson T; Almlöf T; Guldevall K; Steffensen KR; Gustafsson JA J Biol Chem; 2008 Apr; 283(14):8995-9001. PubMed ID: 18263591 [TBL] [Abstract][Full Text] [Related]
13. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434 [TBL] [Abstract][Full Text] [Related]
14. Ras inhibits TGF-β-induced KLF5 acetylation and transcriptional complex assembly via regulating SMAD2/3 phosphorylation in epithelial cells. Guo P; Xing C; Fu X; He D; Dong JT J Cell Biochem; 2020 Mar; 121(3):2197-2208. PubMed ID: 31724223 [TBL] [Abstract][Full Text] [Related]
15. A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Dennler S; Huet S; Gauthier JM Oncogene; 1999 Feb; 18(8):1643-8. PubMed ID: 10102636 [TBL] [Abstract][Full Text] [Related]
16. Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells. Fu Y; Chang A; Chang L; Niessen K; Eapen S; Setiadi A; Karsan A J Biol Chem; 2009 Jul; 284(29):19452-62. PubMed ID: 19473993 [TBL] [Abstract][Full Text] [Related]
17. Novel regulation of vascular endothelial growth factor-A (VEGF-A) by transforming growth factor (beta)1: requirement for Smads, (beta)-CATENIN, AND GSK3(beta). Clifford RL; Deacon K; Knox AJ J Biol Chem; 2008 Dec; 283(51):35337-53. PubMed ID: 18952601 [TBL] [Abstract][Full Text] [Related]
18. Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways. Sugiyama Y; Kakoi K; Kimura A; Takada I; Kashiwagi I; Wakabayashi Y; Morita R; Nomura M; Yoshimura A Int Immunol; 2012 Apr; 24(4):253-65. PubMed ID: 22331441 [TBL] [Abstract][Full Text] [Related]
19. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain. Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931 [TBL] [Abstract][Full Text] [Related]
20. A novel mechanism of TGFbeta-induced actin reorganization mediated by Smad proteins and Rho GTPases. Vardouli L; Vasilaki E; Papadimitriou E; Kardassis D; Stournaras C FEBS J; 2008 Aug; 275(16):4074-87. PubMed ID: 18631173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]